Shanghai Tengrui Pharmaceutical

Shanghai Tengrui Pharmaceutical is a comprehensive pharmaceutical enterprise based in Shanghai, China, specializing in the research, development, and manufacturing of high-end generic and innovative drug products. The company's portfolio is particularly strong in the cardiovascular, digestive, anti-infective, and oncology therapeutic areas, with a focus on complex injectable formulations. Tengrui operates a large-scale, GMP-certified manufacturing base in the Songjiang District, supporting its integrated business model from R&D to commercial sales. Key commercial products include Alprostadil for cardiovascular conditions and Rabeprazole Sodium for gastrointestinal disorders. The company continues to expand its pipeline with a mix of improved generics and novel chemical entities, positioning itself as a significant player in the Chinese domestic market.